Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico

Dengue is a growing public health threat, causing approximately 400 million infections annually. In June 2021, the Advisory Committee on Immunization Practices recommended the first dengue vaccine (CYD-TDV) for children aged 9–16 years with a previous dengue infection, living in endemic areas, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Dania M., Major, Chelsea G., Sánchez-González, Liliana, Jones, Emma, Delorey, Mark J., Alonso, Claudia, Rivera-Amill, Vanessa, Paz-Bailey, Gabriela, Adams, Laura E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160531/
https://www.ncbi.nlm.nih.gov/pubmed/37173267
http://dx.doi.org/10.1016/j.vaccine.2023.04.081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160531/
https://www.ncbi.nlm.nih.gov/pubmed/37173267
http://dx.doi.org/10.1016/j.vaccine.2023.04.081

Ejemplares similares